California state law and California Institute of Regenerative Medicine regulations require that a Stem Cell Research Oversight Committee (SCRO) review and approve all human stem cell research undertaken by UCSB faculty, staff members and students. This review requirement applies to the use of human gametes and blastocysts (embryos), the derivation and/or use of human embryonic stem cells (hESCs), human embryonic or fetal germ cells, human adult and fetal stem cells and any other human pluripotent stem cells.
UCSB has entered into a Memorandum of Understanding (MOU) with the University of California Irvine, to have the UC Irvine SCRO committee serve as UCSB’s SCRO of record. All human stem cell research taking place at UCSB will undergo review and approval by the UC Irvine SCRO. As such, all UC Irvine SCRO policies and procedures now apply to UCSB researchers performing human stem cell research. Activities reviewed and approved by the SCRO may still require additional review by the UCSB IRB, IACUC, IBC and/or COIC committees.
The UCSB SCRO of record is now at UC Irvine. Please visit UCI’s Stem Cell Use site for more information about stem cell research, federal and state stem cell research regulations, and applying to the SCRO.
Please contact Monica regarding Stem Cell approvals between June 1st and October 15, 2022.
Conflict of Interest Analyst
Melodie Blakemore, CPIA
Associate Director, Research Integrity